Updates from Pharmainfo.net website
MADRID (MarketWatch) -- German pharmaceutical and chemicals group Bayer was downgraded to neutral from outperform, with the price target cut to 52 euros from 55 euros on Monday by Credit Suisse.
read more
No comments:
Post a Comment